OLDER PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES (T2DM) EXPERIENCE MORE DELAYED TREATMENT WITH ORAL ANTIHYPERGLYCEMIC AGENTS COMPARED WITH YOUNGER PATIENTS

Author(s)

Zhang Q1, Rajagopalan S2, Marrett E1, Radican L11Merck, Whitehouse Station, NJ, USA, 2MedData Analytics, Inc., Williamsville, NY, USA

OBJECTIVES: This study compared older (≥ 65 yrs) and younger patients with newly diagnosed T2DM, and evaluated factors associated with oral antihyperglycemic agent (OAHA) initiation. METHODS: This retrospective cohort study used U.S. General Electric (GE) Centricity electronic medical record database. Patients aged ≥30 yrs with newly-diagnosed T2DM (January-2003 to December-2005) were included. There was no diabetes diagnosis or treatment within 2 years prior to the first recorded T2DM diagnosis. Medical records 1 year prior to (baseline) and 2 years after (follow-up) diagnosis were extracted. OAHA initiation was estimated based on the first OAHA prescription during follow-up. Multivariable Cox proportional hazards regression model was fitted. Untreated patients were censored at complete 2 years follow-up. RESULTS: Among 10,760 newly diagnosed T2DM patients, 55% were female. Mean age at T2DM diagnosis was 61.3(±12.5), with 4,617 (43%) ≥65 yrs. At baseline, older relative to younger patients had lower HbA1c (6.7% vs. 7.2%, with only 38% vs. 32% attaining HbA1c <7% goal), lower fasting blood glucose (117.9 vs. 132.8 mg/dL) and lower BMI (30.6 vs. 35.2), higher rates of acute myocardial infarction (MI) (2.1% vs. 0.9%), heart failure (5.1% vs. 1.8%), stroke (3.1% vs. 0.8%), and renal disease (17.5% vs. 6.2%), and more co-medications (all p-values <0.05). Within 2 years after T2DM diagnosis, 56% older and 40.5% younger patients (P<0.001) had not received OAHA. Older patients were less likely to be treated than younger patients (adjusted hazard ratio 0.84, p<0.001). Additionally, patients with baseline MI or renal disease were less likely to be treated (p<0.05). Higher BMI or HbA1c at baseline, and heart failure, initiating antihypertensive or lipid lowering drugs after T2DM diagnosis were factors associated with increased likelihood of OAHA treatment (p<0.05).  CONCLUSIONS: Older patients with newly diagnosed T2DM had milder hyperglycemia but more comorbidities, and experienced more delayed OAHA therapy than younger patients.

Conference/Value in Health Info

2010-05, ISPOR 2010, Atlanta, GA, USA

Value in Health, Vol. 13, No. 3 (May 2010)

Code

PDB69

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Prescribing Behavior

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×